By Regulatory Approvals — Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval Pharmaceutical Technology
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 14, 2026.